Manulife (Manufacturers Life Insurance)’s Aratana Therapeutics, Inc. PETX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-32,806
Closed -$169K 2973
2019
Q2
$169K Sell
32,806
-492
-1% -$2.21K ﹤0.01% 2728
2019
Q1
$120K Buy
33,298
+2,338
+8% +$10.1K ﹤0.01% 2554
2018
Q4
$190K Sell
30,960
-3,057
-9% -$18.7K ﹤0.01% 2344
2018
Q3
$199K Sell
34,017
-4,796
-12% -$24K ﹤0.01% 2771
2018
Q2
$165K Buy
38,813
+2,269
+6% +$11.4K ﹤0.01% 3258
2018
Q1
$161K Buy
36,544
+1,405
+4% +$6.27K ﹤0.01% 3185
2017
Q4
$184K Buy
35,139
+1,480
+4% +$9.05K ﹤0.01% 3073
2017
Q3
$207K Sell
33,659
-517
-2% -$3.27K ﹤0.01% 2953
2017
Q2
$248K Buy
34,176
+6,898
+25% +$42.4K ﹤0.01% 2837
2017
Q1
$145K Buy
27,278
+2,740
+11% +$18.5K ﹤0.01% 3019
2016
Q4
$176K Buy
24,538
+102
+0.4% +$825 ﹤0.01% 2882
2016
Q3
$229K Sell
24,436
-216,569
-90% -$1.8M ﹤0.01% 2671
2016
Q2
$1.52M Buy
241,005
+61,789
+34% +$397K ﹤0.01% 1426
2016
Q1
$933K Sell
179,216
-185,955
-51% -$699K ﹤0.01% 1652
2015
Q4
$2.04K Buy
365,171
+190,861
+109% +$1.26M ﹤0.01% 1393
2015
Q3
$1.48K Buy
174,310
+154,440
+777% +$2.61M ﹤0.01% 1456
2015
Q2
$301 Buy
19,870
+741
+4% +$10.7K ﹤0.01% 2505
2015
Q1
$306 Buy
19,129
+295
+2% +$5.25K ﹤0.01% 2419
2014
Q4
$335 Buy
18,834
+2,381
+14% +$29.7K ﹤0.01% 2263
2014
Q3
$165 Buy
16,453
+218
+1% +$2.64K ﹤0.01% 2770
2014
Q2
$253K Buy
16,235
+10,423
+179% +$148K ﹤0.01% 2550
2014
Q1
$108 Buy
5,812
+557
+11% +$11.2K ﹤0.01% 3038
2013
Q4
$100 Buy
+5,255
New +$107K ﹤0.01% 3069

Other funds holding PETX

Manulife (Manufacturers Life Insurance)'s PETX Position: Q3 2019 in Review

Manulife (Manufacturers Life Insurance) sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 32,806 shares — an estimated $169K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PETX in Q4 2013 and held it in 23 quarters. The position peaked at $1.52M in Q2 2016. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

  • Manulife (Manufacturers Life Insurance) reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 32,806 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $169K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Aratana Therapeutics, Inc. in Q4 2013 and held it in 23 quarters.
  • Manulife (Manufacturers Life Insurance)'s Aratana Therapeutics, Inc. position peaked at $1.52M in Q2 2016.
  • 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2019, filed 12 Nov 2019.